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There were 37.8 million people living with HIV/AIDS
worldwide at the end of 2003, and 2.9 million had died in
the past year. HIV/AIDS is spreading unchecked across
Africa and parts of Asia. The African continent has 29.4
million people living with HIV/AIDS, and approximately 4.8
million new infections were recorded in 2003. In Lesotho,
national adult prevalence has reached 31%.1 Lesotho, a
developing country in sub-Saharan Africa with a
population of 2.057 million, reported its first AIDS case in
1986; however, it had 360 000 people living with HIV/AIDS
in 2001.2 In 2000, 59% of the reported full-blown AIDS
cases were clustered in the 20 - 39-year range and the
majority of HIV-positive cases were young females  (aged
less than 19 years).3 Estimation of the HIV/AIDS prevalence
in Lesotho is based on data from sentinel surveillance of
antenatal and sexually transmitted infection clinic
attendees,2 and reported AIDS cases.3 The estimate could be
higher than the actual prevalence according to the Kenya
Demographic and Health Survey.4
Mortality surveillance using the routine vital statistics and
censuses reports can supplement the sentinel surveillance
data and methods are available for correcting under-
registration and misclassification of deaths,5 such as the
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MORTALITY TRENDS




Study design. A retrospective descriptive study of the mortality trend among inpatients at Motebang district hospital in
Lesotho.
Aim. To assess the impact of HIV/AIDS on the mortality of Motebang Hospital inpatients from 1989 to 2003.
Rationale. If the hypothesis that AIDS had modified the mortality in a unique way could be confirmed, mortality trends
could be used to supplement other methods of estimating the impact of HIV/AIDS such as antenatal and sexually
transmitted infections sentinel surveillance.
Methodology. Inpatients’ data were collected from January 1989 to December 2003. The 15-year period was split into
three 5-year periods (1989 - 1993, 1994 - 1998, and 1999 - 2003) and the diagnoses were grouped into Global Burden
of Disease groups I, II, and III. The data were analysed to establish time, gender and age trends.
Results. The mortality rate and number of deaths increased over the 15-year period. Group I (communicable diseases,
maternal, perinatal, and nutritional conditions) contributed 69% of all deaths. The rise in mortality was most pronounced
in the 15 - 49-year age range, progressively forming a ‘bulge’ on the death incidence by age curve, with the female peak
occurring at the 25 - 29-year age category, 5 years earlier than  males. The study found that AIDS-related deaths
accounted for 51 - 65% of total deaths and 70 - 80% of group I deaths. Although the number of the inpatients in group
II was low, there was evidence of increasing burden from non-communicable diseases. However, the burden from group
III (injuries) remained stable.
Conclusion. AIDS modified the mortality trend of the Motebang Hospital inpatients by raising the deaths of younger
adults, thereby deviating from the expected natural trend. This implied that mortality data of the hospital provenance
can provide information necessary for, inter alia, evaluation of the impact of current and future interventions, for
instance, the impact of the proposed provision of antiretroviral drugs.
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Growth Balance Equation by Brass (1975), the Death
Distribution Method by Preston and Coale,6 and the Age
Group Specific Growth Rates Method by Bennett and
Hourichi (1984).7 Cause-of-death attribution depends on
the accuracy of information available at the time of death,
postmortem report, diagnostic technology, skills of the
clinician assigning the diagnosis, and coding in conformity
to a set of specific rules and rubrics such as those specified
in the International Classification of Diseases (ICD). The
quality of cause-of-death attribution is still of concern.8
AIDS-related mortality surveillance proceeds from the
premise that there is an increase in the male mortality in
the 29 - 59-year range and female mortality in the 20 - 49-
year range, with an emergence of a young adult peak,
which occurs 5 years earlier among females.3,9-11
The present study was carried out at Motebang Hospital.
This hospital, with a capacity of 208 beds and situated in
north-western Lesotho, serves Leribe district and is the
second largest hospital in Lesotho. From the hospital
records, data capture sheets were used to collect data from
1 January 1989 to 31 December 2003. The fields were
gender, age, date of admission and discharge, diagnosis
and outcome (discharge or death). Medical officers were
consulted if abbreviations, representing the diagnoses,
could not be deciphered. The data were entered and
analysed using the Epi Info 2002 statistical package, and
each record was assigned a serial number. The diagnoses
were categorised into Global Burden of Disease (GBD)
group I (pre-transitional diagnoses consisting of
communicable diseases, maternal, perinatal and nutritional
conditions), group II (non-communicable diseases), and
group III (injuries). 
Age was categorised into age ranges that exhibited similar
characteristics and were comparable internationally. These
ranges were 0 - 4, 5 - 14, 15 - 49 and ≥ 50 years. For the
findings to be considered significant, it was predetermined
that a trend had to be set and/or each cell had to have at
least 150 units. To investigate the time trend, data for each
year were used on the death incidence by age curve and a
trend was evident. However, for other calculations such as
mortality rate, a trend could not be set and most of the
cells had less than 150 units. Therefore, the data were
grouped into three 5-year periods (1989 - 1993, 1994 -
1998 and 1999 - 2003), which satisfied the predetermined
requirements.
The estimate of the 1999 - 2003 mortality attributable to
AIDS was computed against the backdrop of the following
assumptions:
■ The deaths for the period 1989 - 1993 were taken as
baseline as they were assumed to have been largely
non-AIDS related.
■ Although in absence of HIV/AIDS health improvement
gains were expected, it was assumed that difficult
economic conditions impacted negatively on social
spending, negating these gains.
■ HIV/AIDS-related deaths were assumed to be the sum
of deaths directly caused by HIV/AIDS, and those that
were indirectly related to it. For instance, HIV/AIDS may
have shifted substantial focus and resources from other
conditions. In addition, children orphaned by AIDS,
unlike other children, are more likely to die irrespective
of their HIV status.12
The study protocol was approved by the Lesotho Ministry
of Health and Social Welfare and the University of the
Western Cape research ethics committee.
DEMOGRAPHY
A total of 24 328 inpatients were recorded from 1989 to
2003. Females and males accounted for 52% and 48%
respectively (Fig. 1). Age was available for 85% of
inpatients, recorded as ‘adult’ for 13.5% ,and missing for
1.5%. The 0 - 4-year category accounted for the largest
proportion (26.5%). The age range decreased to a low level
in the 10 - 14-year category before rising to a peak in the
20 - 24-year category and gradually declining thereafter
(Fig. 2).
MORTALITY
Among all the inpatients, 8.7% died and of these 54.9%




































































































Fig. 2. Motebang Hospital inpatients by age, 1989 - 2003.
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largest proportion of deaths (29.2%). Mortality then
dropped to 1.5% in the age category 15 - 19 years. It then
rose to a peak of 7.1% in the age category 30 - 34 before
declining gradually (Fig. 3). The ‘adult’ category contributed
18.7% of the total mortality. 
Between 1989 - 1993 and 1999 - 2003, the mortality rate
increased by more than twofold (Fig. 4). This increase in
mortality progressively caused a bulge between 15 and 49
years. In the first and second periods (1989 - 1993 and
1994 - 1998) the bulge was not as evident as it was in the
third period (1999-2003) (Fig. 5). Mortality rate per 1 000
population in the over 50 years category was the highest,
followed by the 0 - 4 years, and 15 - 49 years categories.
The lowest mortality rate was in the 5 - 14 years category
(Fig. 6).
MORTALITY AND GENDER
There were more deaths among females than males. For
inpatients in the 15 - 49-year range, the peak for females
was between 25 and 29 years and that for males  between
30 and 34 years. The peak for females occurred 5 years
earlier than for males (Fig. 7). In the ‘adult’ category, more
males were admitted and there was a correspondingly
higher death incidence throughout the study period.
Although the mortality rate was higher in the ‘adult’
category, its male curve mimicked the unique trend of that
of males in the 30 - 49-year range. In this range, the male
mortality rate curve rose steeply from 1989  - 1993 to 1994
- 1998 and then dramatically declined.  The female curves
had some similarities in that they were parallel up to 1994
- 1998, and then the mortality rate decelerated (Fig. 8).
MORTALITY AND GBD CLASSIFICATION
Groups I, II, and III had 54%, 13% and 30% of inpatients
respectively, and the inpatients increased from 1989 - 1993
to 1999 - 2003, except in group III, which showed a slight
reduction (Fig. 9). The death rate for group III was the
lowest and its increase from 1989 - 1993 to 1999 - 2003
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Fig. 8. Motebang Hospital death rates for 30 - 49 years and




























Fig. 9. Motebang Hospital inpatients per GBD group for the
three 5-year periods.
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the trend in group III, the death rate trends in groups I and
II were similar (Fig. 10). When the data for each group in
the 15 - 49-year range were excluded from the death
incidence graphs, group I exclusion resulted in a deviation
from the trend of the total deaths but exclusion of  groups
II and III did not (Fig. 11).
As was expected, the death incidence was high in the 0 - 4-
year category, it then declined through the 5 - 9-year
category to a low level in the 10 - 19-year category.
However, instead of rising gradually, the mortality rose
rapidly forming a bulge on the death incidence curve
between 20 and 49 years. Females peaked between 25 and
29 years and males between 30 and 34 years, a 5-year
difference. This unusual bulge was completely absent in the
period 1989 -1993, incipient in 1994 - 1998 and clearly
evident in 1999 - 2003. In addition, it was limited to group
I conditions. The trend exhibited similarities to that of
known AIDS-related deaths in Lesotho, Zimbabwe and the
ASSA 2000 prediction model, and South African
mortality.3,9-11 Given that the first case of HIV in Lesotho
was in 1986,3 and that HIV-infected people take an average
of 10 years (in the absence of antiretroviral therapy) to
develop full-blown AIDS,13 this peak coincided with the
period when AIDS-related mortality had gained
momentum. The timing, age range and a trend that mimics
that of confirmed AIDS-related mortality in Lesotho3 held
AIDS culpable, and this conclusion had been drawn in
South Africa and Zimbabwe, where similar trends have
been documented.9-10
In this study, the AIDS-related trend was not evident in the
first period (1989 - 1993). It started emerging in the second
period (1994 - 1998), and was well established in the last
(1999 - 2003). The mortality in the first period was
therefore assumed to have been largely non-AIDS-related
and used as a benchmark. For the period 1999 - 2003, using
this benchmark, 51% of all the deaths, and 70% of the
deaths in group I, were AIDS-related. These figures rose to
65% and 80% respectively when the deaths were adjusted
to account for inpatients discharged to community care.
The degree of validity of the adjusted figures can be
considered high in view of the facts that data were of
hospital provenance, and that communicable diseases, the
main subset of group I, contributed 60% of total disease
burden in Africa.12
Unlike other age groups, group I mortality rates in the
‘adult’ and 30 - 49-year categories doubled between 
1989 - 1993 and 1994 - 1998, after which they dropped to
the initial level, although the number of inpatients
remained high. This had been observed in a Kenyan
national referral hospital14 and a rural South African
hospital.15 The drop after the second period was more
dramatic among males than females. One could speculate
that this unexpected trend was related to health care
beneficiaries and/or health care providers. It is probable
that from 1989 - 1993 to 1994 - 1998 the population had
not fully appreciated the impact of HIV/AIDS on their
health, and therefore  still had confidence in the efficacy of
the health services. Consequently, they continued to seek
health services and therefore more AIDS patients died in
the hospital as the incidence of AIDS rose. However, from
1994 - 1998 to 1999 - 2003, information about AIDS was
spreading and diagnoses were being made. Patients and
relatives were realising that AIDS was a terminal illness,
and they only sought admission for acute conditions and
thereafter requested  discharge. 
Another reason could have been prohibitive cost of a
protracted stay in hospital for the majority of patients and
their relatives. In addition, social reasons such as stigma
associated with AIDS, and intractable and embarrassing
conditions such as chronic diarrhoea, could have lowered
the threshold for eschewing hospital care. On the other
hand, health care provider-related factors could have
provided an alternative explanation. The health care
providers may have encouraged patients to be cared for at
home for two reasons. Firstly, this would have decongested
the wards and allowed more patients suffering from other
conditions to be admitted. If this were the case, it would
have signified a health delivery system that was being
overwhelmed by chronic end-stage disease. The risk of
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Fig. 11. Motebang Hospital total deaths and deaths excluding
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Fig. 10. Death rates in Motebang Hospital groups I, II and III
inpatients by 3-year periods.
THE SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE                                            AUGUST 2004  37
early stages of the HIV epidemic.16 This school of thought,
however, still lacks empirical corroboration. For instance, a
baseline assessment for health sector reform in Lesotho
reported a bed occupancy rate of 58%.17 Besides availability
of beds, limitation of other resources could have
encumbered hospital services, but a study carried out in a
Nairobi hospital in Kenya nullified the hypothesis that
hospital services were likely to collapse under the burden of
HIV/AIDS.14 Secondly, the health care providers could have
encouraged utilisation of community- and home-based
care health services. Whatever the reason, it was clear that
many patients were probably dying at home, thus shifting
the burden to the nascent community and home-based
care.
The death rate of males (in the ‘adult’ and 30 - 49-year age
categories) fell dramatically from 1994 - 1998 to 
1999 - 2003, while the decrease for females was not as
dramatic. Common factors must have been driving the
mortality rate for both males and females; however, it is
probable that the maternal conditions were confounding
the trend of the female curves. A study found that the
maternal death rate variable was proportional to the HIV
prevalence variable.18 Moreover, the 1999 confidential
enquiry into maternal deaths of the South African
Department of Health stated that AIDS was clearly
demonstrated to have a heavy impact on maternal death,
reporting that of the 35.5% of maternal deaths with HIV
sero-status, 68% were HIV- positive.19 It is probable that
the difference between male and female mortality rates
from 1994 to 1998 can be attributed to the impact of AIDS
on maternal mortality.
Although group II had only 13% of inpatients, it
contributed 17% of the total deaths. The number of
inpatients and death rates in group II increased over the
15-year period covered. The death rate increased at the
same rate as that of group I, suggesting progress into a
double burden scenario of pre-transitional and non-
communicable conditions. This is consistent with the WHO
observation that, in Africa, the burden of non-
communicable diseases continued to increase in tandem
with communicable diseases.12 However, the rate of
progress into the double-burden scenario may differ from
one country to the other. For instance, in 2003 group II was
responsible for 15% of deaths, which was lower than the
37% reported in South Africa in 2000.20 This is probably
because Lesotho had a shorter life expectancy at birth (35.7
years, 2002) than South Africa (50.7 years, 2002),12 and
therefore fewer people reached old age to succumb to
chronic non-communicable diseases. Secondly, Lesotho
could have been lagging behind South Africa in
epidemiological transition. 
Group III had 30% of inpatients but contributed the lowest
portion of deaths (10%). The number of inpatients declined
slightly between 1989 - 1993 and 1999 - 2003, while the
death rate rose marginally. Males accounted for 61% of
injuries, indicating that they shoulder a heavier burden of
injuries, as has been reported in South Africa (males 74%)20
and estimated by the World Health Organisation (WHO)
(males 70%).12 The higher burden of injuries among males
in Lesotho could probably be ascribed to their higher risk
for, inter alia, road traffic accidents and interpersonal
violence. Despite this stability, the WHO fears an
exponential rise in road traffic-related injuries in
developing countries and warns against complacency.12
The HIV/AIDS pandemic has had a huge impact on the
inpatient mortality in Lesotho, and it has modified the
trend in a similar way as reported in Zimbabwe and South
Africa and as predicted by the ASSA 2000 prediction model.
The ASSA 2000 model was used to make similar predictions
in Lesotho. It appears that the AIDS burden is shifting from
the hospitals to the homes and communities, which in turn
may require additional resources to cope with the
increasing demand. AIDS may be accelerating maternal
mortality, but this requires further investigation. In
addition, the pandemic in Lesotho is progressing into a
double-burden scenario of pre-transitional and non-
communicable conditions. The injuries-related burden has
remained stable, although this cannot justify complacency.  
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CONCLUSION
